163 related articles for article (PubMed ID: 32815758)
1. Incidence and risk factors for radioactive iodine-induced sialadenitis.
Sánchez Barrueco A; González Galán F; Alcalá Rueda I; Santillán Coello JM; Barrio Dorado MP; Villacampa Aubá JM; Escanciano Escanciano M; Llanos Jiménez L; Mahillo Fernández I; Cenjor Español C
Acta Otolaryngol; 2020 Nov; 140(11):959-962. PubMed ID: 32815758
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
[No Abstract] [Full Text] [Related]
3. Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.
Kim YM; Choi JS; Hong SB; Hyun IY; Lim JY
Head Neck; 2016 Jan; 38(1):51-8. PubMed ID: 24995941
[TBL] [Abstract][Full Text] [Related]
4. Sialendoscopy-assisted treatment for radioiodine-induced sialadenitis.
Wu CB; Xi H; Zhou Q; Zhang LM
J Oral Maxillofac Surg; 2015 Mar; 73(3):475-81. PubMed ID: 25544300
[TBL] [Abstract][Full Text] [Related]
5. Interventional sialendoscopy for treatment of radioiodine-induced sialadenitis.
Bomeli SR; Schaitkin B; Carrau RL; Walvekar RR
Laryngoscope; 2009 May; 119(5):864-7. PubMed ID: 19266587
[TBL] [Abstract][Full Text] [Related]
6. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
Caglar M; Tuncel M; Alpar R
Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic sialendoscopy for the management of radioiodine sialadenitis.
Prendes BL; Orloff LA; Eisele DW
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):15-9. PubMed ID: 22249623
[TBL] [Abstract][Full Text] [Related]
8. Sialadenitis after radioiodine therapy. Analysis of factors that influence the response to medical treatment.
Geres AE; Mereshian PS; Fernández S; Rey Caro DG; Castro R; Podio R; Ojeda S
Endocrinol Nutr; 2015 Dec; 62(10):493-8. PubMed ID: 26459118
[TBL] [Abstract][Full Text] [Related]
9. Sialendoscopy in the Management of Radioiodine Induced Sialadenitis: A Systematic Review.
Cung TD; Lai W; Svider PF; Hanba C; Samantray J; Folbe AJ; Shkoukani M; Raza SN
Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):768-773. PubMed ID: 28949251
[TBL] [Abstract][Full Text] [Related]
10. Impact of sialendoscopy on improving health related quality of life in patients suffering from radioiodineinduced xerostomia.
Bulut OC; Haufe S; Hohenberger R; Hein M; Kratochwil C; Rathke H; Plinkert PK; Baumann I; Holland-Letz T; Haberkorn U; Flechsig P
Nuklearmedizin; 2018 Aug; 57(4):160-167. PubMed ID: 30125928
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Patient Salivary Radioiodine Transit and Dysfunction Assessment Using Chewing Gums.
Okkalides D
Cancer Biother Radiopharm; 2016 Nov; 31(9):330-341. PubMed ID: 27831763
[TBL] [Abstract][Full Text] [Related]
12. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.
Lee SM; Lee JW; Kim SY; Han SW; Bae WK
Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836
[TBL] [Abstract][Full Text] [Related]
13. Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?
Adramerinas M; Andreadis D; Vahtsevanos K; Poulopoulos A; Pazaitou-Panayiotou K
Hormones (Athens); 2021 Dec; 20(4):669-678. PubMed ID: 34143403
[TBL] [Abstract][Full Text] [Related]
14. Sialoendoscopic treatment for radioiodine induced sialadenitis.
Kim JW; Han GS; Lee SH; Lee DY; Kim YM
Laryngoscope; 2007 Jan; 117(1):133-6. PubMed ID: 17202942
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human thyroid-stimulating hormone or levothyroxine withdrawal on salivary gland dysfunction after radioactive iodine administration for thyroid remnant ablation.
Iakovou I; Goulis DG; Tsinaslanidou Z; Giannoula E; Katsikaki G; Konstantinidis I
Head Neck; 2016 Apr; 38 Suppl 1():E227-30. PubMed ID: 25537365
[TBL] [Abstract][Full Text] [Related]
16. [Studies on newly recognized chronic sialadenitis].
Yu GY; Liu DG; Li W; Hong X; Zhang YY; Zhu WX; Zhang KF; Li X; Li ZG; Liu YY; Chen Y; Gao Y; Su JZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 54(1):13-17. PubMed ID: 35165462
[TBL] [Abstract][Full Text] [Related]
17. [Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].
Macioszek A; Baczyk M; Kopeć T; Sowiński J
Endokrynol Pol; 2008; 59(5):403-10. PubMed ID: 18979451
[TBL] [Abstract][Full Text] [Related]
18. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer.
An YS; Yoon JK; Lee SJ; Song HS; Yoon SH; Jo KS
Ann Nucl Med; 2013 May; 27(4):386-91. PubMed ID: 23389626
[TBL] [Abstract][Full Text] [Related]
20. Interventional sialendoscopy for radioiodine-induced sialadenitis: quo vadis?
Canzi P; Cacciola S; Capaccio P; Pagella F; Occhini A; Pignataro L; Benazzo M
Acta Otorhinolaryngol Ital; 2017 Apr; 37(2):155-159. PubMed ID: 28516979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
